Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BioAge Labs, Inc. | Chief Executive Officer, Director | Common Stock | 1.21M | $21.8M | $18.00 | Sep 25, 2024 | Direct |
BioAge Labs, Inc. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 530K | Feb 18, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BIOA | BioAge Labs, Inc. | Feb 18, 2025 | 1 | $0 | 4 | Feb 20, 2025 | Chief Executive Officer, Director |
BIOA | BioAge Labs, Inc. | Sep 25, 2024 | 0 | $0 | 3 | Sep 25, 2024 | Chief Executive Officer, Director |
BIOA | BioAge Labs, Inc. | Apr 17, 2024 | 2 | $0 | 4 | Sep 27, 2024 | Chief Executive Officer, Director |